🚦Technical Amendments to Highway Safety Grant Procedures
This final rule makes technical amendments to the Uniform Procedures for State Highway Safety Grant Programs to remove references to rescinded Executive Orders.
Learn More🚆Proposed Removal of Redundant Regulations in Railroad Industry
FRA intends to remove thirteen sections throughout its regulations that unnecessarily recite the approval of information collection requirements by the Office of Management and Budget (OMB), state the assigned OMB control number associated with the entire CFR part, and list the sections in that part with information collection requirements.
Learn More🚂Update on the Definition of "Person" in Railroad Regulations
This final rule updates the definition of "person" in FRA's regulations to provide for regulatory consistency. FRA is making these clarifying changes to better align with FRA's safety jurisdiction and to conform definitions in FRA's older regulations with the definition of "person" that FRA has used in its most recent rulemakings. In one section where "person" is defined, FRA is also replacing references to specific penalty amounts with general references to FRA's minimum civil monetary penalty, ordinary maximum civil monetary penalty, and aggravated maximum civil monetary penalty amounts, consistent with FRA's current practice.
Learn More🚆Updates to Railroad Alcohol and Drug Use Regulations
This rule makes administrative updates to FRA's control of alcohol and drug use regulations, including updating addresses.
Learn More🚚Proposed Rule to Eliminate CDL Self-Reporting Requirement
FMCSA proposes to revise its regulations requiring commercial driver's license (CDL) holders to self-report motor vehicle violations to their State of domicile. With the implementation of the exclusive electronic exchange of violations between State drivers licensing agencies (SDLAs) in 2024, self-reporting is no longer necessary. This action supports the Administration's deregulatory efforts.
Learn More🚛FMCSA Proposes CDL Standards Exemption for Military Technicians
FMCSA proposes to amend the Federal Motor Carrier Safety regulations (FMCSRs) to allow dual-status military technicians to qualify for the exception for certain military personnel from commercial driver license (CDL) standards. This rulemaking responds to a petition for rulemaking submitted by James D. Welch.
Learn More🚦Proposed Regulation on Railroad Grade Crossings for CMVs
FMCSA proposes to amend the regulations related to driving a commercial motor vehicle (CMV) at railroad grade crossings. Currently, drivers of certain CMVs (e.g., buses transporting passengers and CMVs transporting certain hazardous materials) are required to stop before crossing a railroad track unless an exception applies, such as when the crossing is controlled by a functioning highway traffic signal transmitting a green indication. The Agency proposes to add a similar exception for a railroad grade crossing equipped with an active warning device that is not in an activated state (e.g., flashing lights or crossing gates down, indicating the arrival of a train).
Learn More🚚FMCSA Proposal to Remove Liquid-Burning Flares from Regulations
FMCSA proposes to remove references to liquid-burning flares from the warning device requirements in the Federal Motor Carrier Safety Regulations (FMCSRs). This proposed revision would remove outdated language referring to warning devices that FMCSA believes are no longer used.
Learn More🧠NIH Brain Development Cohorts Data Use Certification Review Notice
In compliance with the Paperwork Reduction Act of 1995, the National Institutes of Health (NIH) has submitted to the Office of Management and Budget (OMB) a request for review and approval of the information collection listed below.
Learn More📅Cancellation Notice of National Institute on Drug Abuse Meeting
The Department of Health and Human Services has officially canceled the scheduled meeting for the National Institute on Drug Abuse Special Emphasis Panel. No rescheduling will occur, and the cancellation notice follows a previously published announcement. The meeting was set to take place in April 2025 at the NIH headquarters in Bethesda, MD.
Learn More